发明名称 NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED THERAPEUTIC PROTEIN
摘要 The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a therapeutic protein or a fragment, variant or derivative thereof, at least one histone stem-loop and a poly(A) sequence or a polyadenylation signal. Furthermore the present invention provides the use of the nucleic acid for increasing the expression of said encoded peptide or protein, particularly for the use in gene therapy. It also discloses its use for the preparation of a pharmaceutical composition, e.g. for use in gene therapy, particularly in the treatment of diseases which are in need of a treatment with a therapeutic peptide or protein, preferably as defined herein. The present invention further describes a method for increasing the expression of a peptide or protein comprising a therapeutic protein or a fragment, variant or derivative thereof, using the nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal.
申请公布号 US2017056529(A1) 申请公布日期 2017.03.02
申请号 US201615233933 申请日期 2016.08.10
申请人 CureVac AG 发明人 THESS Andreas;SCHLAKE Thomas;PROBST Jochen
分类号 A61K48/00;C12N15/67;C12N15/85;C07K14/505;C07K16/32 主分类号 A61K48/00
代理机构 代理人
主权项 1. Nucleic acid sequence comprising or coding for a) a coding region, encoding at least one peptide or protein; b) at least one histone stem-loop, and c) a poly(A) sequence or a polyadenylation signal; wherein said peptide or protein comprises a therapeutic protein or a fragment, variant or derivative thereof, selected from (i) therapeutic proteins for use in the treatment of metabolic or endocrine disorders,(ii) therapeutic proteins for use in the treatment of blood disorders, diseases of the circulatory system, diseases of the respiratory system, cancer or tumour diseases, infectious diseases or immunedeficiencies,(iii) therapeutic proteins used for hormone replacement therapy,(iv) therapeutic proteins used for reprogramming of somatic cells into pluri- or omnipotent stem cells,(v) therapeutic proteins selected from adjuvant or immunostimulating proteins; and(vi) antibodies.
地址 Tubingen DE